{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:04:50Z","timestamp":1759334690047,"version":"build-2065373602"},"reference-count":40,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.jfo.2023.03.011","type":"journal-article","created":{"date-parts":[[2023,8,4]],"date-time":"2023-08-04T08:42:06Z","timestamp":1691138526000},"page":"e312-e316","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["N\u00e9ovascularisation choro\u00efdienne secondaire \u00e0 un foyer cicatriciel de toxoplasmose maculaire\u00a0: \u00e0 propos d\u2019un cas chez une enfant de 11\u00a0ans"],"prefix":"10.1016","volume":"46","author":[{"given":"A.","family":"Smaoui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Chassery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Mesnard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Merle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfo.2023.03.011_bib0205","first-page":"211","article-title":"Toxoplasmic choroiditis and subretinal neovessels","volume":"7","author":"Skorska","year":"1984","journal-title":"J Fr Ophtalmol"},{"key":"10.1016\/j.jfo.2023.03.011_bib0210","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/0002-9394(81)90283-X","article-title":"Choroidal neovascularization as a late complication of ocular toxoplasmosis","volume":"91","author":"Fine","year":"1981","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2023.03.011_bib0215","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/S0161-6420(82)34642-4","article-title":"Toxoplasma retinochoroiditis","volume":"89","author":"Noble","year":"1982","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2023.03.011_bib0220","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1136\/bjo.66.8.524","article-title":"Subretinal neovascularisation in ocular toxoplasmosis","volume":"66","year":"1982","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jfo.2023.03.011_bib0225","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.3129\/i10-087","article-title":"Choroidal neovascularization secondary to congenital toxoplasmosis in an infant","volume":"45","author":"Mavrikakis","year":"2010","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.jfo.2023.03.011_bib0230","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12348-015-0051-2","article-title":"Coexisting choroidal neovascularization and active retinochoroiditis\u00a0\u2013\u00a0an uncommon presentation of ocular toxoplasmosis","volume":"5","author":"Hegde","year":"2015","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"10.1016\/j.jfo.2023.03.011_bib0235","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1136\/bjo.2007.124586","article-title":"Choroidal neovascularisation in children","volume":"92","author":"Sivaprasad","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jfo.2023.03.011_bib0240","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/S0161-6420(96)30515-0","article-title":"Etiology of choroidal neovascularization in young patients","volume":"103","author":"Cohen","year":"1996","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2023.03.011_bib0245","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3928\/0191-3913-19880101-07","article-title":"Choroidal neovascularization in children: report of five cases and literature review","volume":"25","author":"Wilson","year":"1988","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"10.1016\/j.jfo.2023.03.011_bib0250","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/00055735-199906000-00005","article-title":"Choroidal neovascularization in younger patients","volume":"10","author":"Spaide","year":"1999","journal-title":"Curr Opin Ophthalmol juin"},{"key":"10.1016\/j.jfo.2023.03.011_bib0255","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s10792-021-02018-2","article-title":"Choroidal neovascularization in 111\u00a0eyes of children and adolescents","volume":"42","author":"Rishi","year":"2022","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.jfo.2023.03.011_bib0260","doi-asserted-by":"crossref","first-page":"62","DOI":"10.4103\/0301-4738.73728","article-title":"Combination photodynamic therapy and bevacizumab for choroidal neovascularization associated with toxoplasmosis","volume":"59","author":"Rishi","year":"2011","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.jfo.2023.03.011_bib0265","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/00006982-200604000-00003","article-title":"Verteporfin photodynamic therapy for choroidal neovascularization associated with toxoplasmic retinochoroiditis","volume":"26","author":"Mauget-Fa\u00ffsse","year":"2006","journal-title":"Retina"},{"key":"10.1016\/j.jfo.2023.03.011_bib0270","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1001\/archopht.126.8.1152","article-title":"Toxoplasmosis-associated neovascular lesions treated successfully with ranibizumab and antiparasitic therapy","volume":"126","author":"Benevento","year":"2008","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jfo.2023.03.011_bib0275","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1097\/00006982-200507000-00009","article-title":"Photodynamic therapy for choroidal neovascularization in pediatric patients","volume":"25","author":"Giansanti","year":"2005","journal-title":"Retina"},{"key":"10.1016\/j.jfo.2023.03.011_bib0280","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1159\/000512286","article-title":"Toxoplasma retinochoroiditis with chorioretinal neovascularization in a young patient","volume":"12","author":"Khandwala","year":"2021","journal-title":"Case Rep Ophthalmol"},{"key":"10.1016\/j.jfo.2023.03.011_bib0285","doi-asserted-by":"crossref","first-page":"318","DOI":"10.4103\/0301-4738.82005","article-title":"Intravitreal ranibizumab for the treatment of choroidal neovascularization secondary to ocular toxoplasmosis","volume":"59","author":"Shah","year":"2011","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.jfo.2023.03.011_bib0290","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.jfo.2016.04.004","article-title":"Neovascular membrane secondary to toxoplasma scar","volume":"39","author":"Sastre-Ib\u00e1\u00f1ez","year":"2016","journal-title":"J Fr Ophtalmol"},{"key":"10.1016\/j.jfo.2023.03.011_bib0295","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1097\/IAE.0000000000001710","article-title":"Inflammatory choroidal neovascular membrane: long-term visual and anatomical outcomes after intravitreal antivascular endothelial growth factor therapy","volume":"38","author":"D\u02bcSouza","year":"2018","journal-title":"Retina"},{"key":"10.1016\/j.jfo.2023.03.011_bib0300","first-page":"3158","article-title":"VEGF is major stimulator in model of choroidal neovascularization","volume":"41","author":"Kwak","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jfo.2023.03.011_bib0305","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.oret.2021.05.015","article-title":"Etiology, treatment patterns, and outcomes for choroidal neovascularization in the pediatric population: an Intelligent Research in Sight (IRIS\u00ae) registry study","volume":"6","author":"Finn","year":"2022","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.jfo.2023.03.011_bib0310","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jcjo.2012.03.042","article-title":"Three-year visual and anatomic results of administrating intravitreal bevacizumab in inflammatory ocular neovascularization","volume":"47","author":"Mansour","year":"2012","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.jfo.2023.03.011_bib0315","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1097\/IAE.0b013e3181c96a00","article-title":"Bevacizumab for choroidal neovascularization related to inflammatory diseases","volume":"30","author":"Kramer","year":"2010","journal-title":"Retina"},{"key":"10.1016\/j.jfo.2023.03.011_bib0320","first-page":"e20195","article-title":"Response of pediatric choroidal neovascularization to antivascular endothelial growth factor","volume":"13","author":"Ruparelia","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.jfo.2023.03.011_bib0325","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3109\/08820538.2013.838278","article-title":"Intravitreal bevacizumab for treatment of choroidal neovascularization secondary to toxoplasmic retinochoroiditis: a case series","volume":"30","author":"Kianersi","year":"2015","journal-title":"Semin Ophthalmol"},{"key":"10.1016\/j.jfo.2023.03.011_bib0330","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s10792-008-9218-2","article-title":"Intravitreal bevacizumab (Avastin) as primary and rescue treatment for choroidal neovascularization secondary to ocular toxoplasmosis","volume":"28","author":"Ben Yahia","year":"2008","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.jfo.2023.03.011_bib0335","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1111\/j.1755-3768.2008.01319.x","article-title":"Intravitreal bevacizumab for choroidal neovascularization in toxoplasmosis","volume":"87","author":"Guthoff","year":"2009","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.jfo.2023.03.011_bib0340","first-page":"86","article-title":"Intravitreal ranibizumab for the treatment of choroidal neovascularization secondary to ocular toxoplasmosis","volume":"61","author":"Pandey","year":"2013","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.jfo.2023.03.011_bib0345","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1097\/IAE.0b013e3182003ca8","article-title":"Intravitreal ranibizumab for the treatment of inflammatory choroidal neovascularization","volume":"31","author":"Rouvas","year":"2011","journal-title":"Retina"},{"key":"10.1016\/j.jfo.2023.03.011_bib0350","doi-asserted-by":"crossref","first-page":"141","DOI":"10.4103\/0974-620X.142598","article-title":"Paediatric choroidal neovascular membrane secondary to toxoplasmosis treated successfully with antivascular endothelial growth factor","volume":"7","author":"Mathur","year":"2014","journal-title":"Oman J Ophthalmol"},{"key":"10.1016\/j.jfo.2023.03.011_bib0355","doi-asserted-by":"crossref","first-page":"114","DOI":"10.5114\/ko.2022.116832","article-title":"Eye toxoplasmosis complicated by choroidal neovascularization effectively treated with the anti-vascular endothelial growth factor aflibercept","volume":"124","author":"Sienicka","year":"2022","journal-title":"Klinika Oczna"},{"key":"10.1016\/j.jfo.2023.03.011_bib0360","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.2147\/OPTH.S132923","article-title":"Intravitreal aflibercept for choroidal neovascularization associated with chorioretinitis: a pilot study","volume":"11","author":"Korol","year":"2017","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.jfo.2023.03.011_bib0365","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ajo.2017.08.005","article-title":"Disorganization of the retinal inner layers as a predictor of visual acuity in eyes with macular edema secondary to vein occlusion","volume":"182","author":"Mimouni","year":"2017","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2023.03.011_bib0370","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1007\/s00417-004-0894-y","article-title":"Photodynamic therapy-treated choroidal neovascular membrane secondary to toxoplasmic retinochoroiditis","volume":"242","author":"Oliveira","year":"2004","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.jfo.2023.03.011_bib0375","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S0002-9394(02)01947-5","article-title":"Surgery for subfoveal choroidal neovascularization in toxoplasmic retinochoroiditis","volume":"135","author":"Ad\u00e1n","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2023.03.011_bib0380","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/00006982-199616030-00002","article-title":"The surgical removal of subfoveal choroidal neovascularization. Ingrowth site as a predictor of visual outcome","volume":"16","author":"Melberg","year":"1996","journal-title":"Retina"},{"key":"10.1016\/j.jfo.2023.03.011_bib0385","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1001\/archopht.118.10.1373","article-title":"Visual outcome after surgical removal of choroidal neovascularization in pediatric patients","volume":"118","author":"Uemura","year":"2000","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jfo.2023.03.011_bib0390","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/00006982-200208000-00003","article-title":"Surgical outcome for removal of subfoveal choroidal neovascular membranes in children","volume":"22","author":"Jain","year":"2002","journal-title":"Retina"},{"key":"10.1016\/j.jfo.2023.03.011_bib0395","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s40942-020-00231-2","article-title":"New findings useful for clinical practice using swept-source optical coherence tomography angiography in the follow-up of active ocular toxoplasmosis","volume":"6","author":"De Oliveira Dias","year":"2020","journal-title":"Int J Retina Vitreous"},{"key":"10.1016\/j.jfo.2023.03.011_bib0200","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3928\/23258160-20170601-11","article-title":"OCTA imaging of choroidal neovascular membrane secondary to toxoplasma retinochoroiditis","volume":"48","author":"T\u00fcrkc\u00fc","year":"2017","journal-title":"Ophthal Surg Lasers Imaging Retina"}],"container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0181551223002929?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0181551223002929?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:20:58Z","timestamp":1759260058000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0181551223002929"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":40,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S0181551223002929"],"URL":"https:\/\/doi.org\/10.1016\/j.jfo.2023.03.011","relation":{},"ISSN":["0181-5512"],"issn-type":[{"type":"print","value":"0181-5512"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"N\u00e9ovascularisation choro\u00efdienne secondaire \u00e0 un foyer cicatriciel de toxoplasmose maculaire\u00a0: \u00e0 propos d\u2019un cas chez une enfant de 11\u00a0ans","name":"articletitle","label":"Article Title"},{"value":"Journal Fran\u00e7ais d'Ophtalmologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfo.2023.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}